Skip to content

Clinical trials

Recruiting Cardiomyopathy, Hypertrophic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Status: Recruiting Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20171
20201
20221
20231
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases4
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Bristol-Myers Squibb1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Peking Union Medical College Hospital1
Shandong Suncadia Medicine Co., Ltd.1
SuZhou Sinus Medical Technologies Co.,Ltd1
Xiang Wei1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic12
Cardiomyopathy, Dilated2
Arrhythmogenic Right Ventricular Dysplasia1
Atrial Fibrillation1
Cardiovascular Diseases1
Hypertrophy, Left Ventricular1
Mitral Valve Insufficiency1
Myocardial Infarction1
Myocarditis1
Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.